Search

Displaying results 8431 - 8440 of 10000 in total
  1. Drug

    Fenaperone

    go.drugbank.com/drugs/DB21281
    Experimental

    Fenaperone has a monoisotopic molecular weight of 376.22 Da. … Fenaperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Fenaperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  2. Drug

    Metrenperone

    go.drugbank.com/drugs/DB21312
    Experimental

    Metrenperone has a monoisotopic molecular weight of 407.2 Da. … Metrenperone is a small molecule drug. The usage of the INN stem '-perone' in the name indicates that Metrenperone is a tranquillizer, neuroleptic, 4'-fluoro-4-piperidinobutyrophenone derivative.

  3. Drug

    Acefylline clofibrol

    go.drugbank.com/drugs/DB21353
    Experimental

    Acefylline clofibrol has a monoisotopic molecular weight of 420.12 Da. … Acefylline clofibrol is a small molecule drug. The usage of the INN stem '-fylline' in the name indicates that Acefylline clofibrol is a N-methylated xanthine derivative.

  4. Drug

    Nelutroctiv

    go.drugbank.com/drugs/DB21554
    Investigational

    Nelutroctiv has a monoisotopic molecular weight of 543.13 Da. … Nelutroctiv is a small molecule drug. Nelutroctiv is under investigation in clinical trial NCT05662215 (A Single and Multiple Ascending Dose Study of CK-3828136 in Healthy Adult Participants).

  5. Drug

    Sofnobrutinib

    go.drugbank.com/drugs/DB21626
    Experimental

    Sofnobrutinib has a monoisotopic molecular weight of 498.19 Da. … Sofnobrutinib is a small molecule drug. The usage of the INN stem '-brutinib' in the name indicates that Sofnobrutinib is a agammaglobulinaemia tyrosine kinase (Bruton tyrosine kinase) inhibitor.

  6. Drug

    Lacutoclax

    go.drugbank.com/drugs/DB21657
    Investigational

    Lacutoclax has a monoisotopic molecular weight of 922.36 Da. … Lacutoclax is a small molecule drug. The usage of the INN stem '-toclax' in the name indicates that Lacutoclax is a B-cell lymphoma 2 (Bcl-2) inhibitor.

  7. Drug

    Vilzemetkib

    go.drugbank.com/drugs/DB21704
    Experimental

    Vilzemetkib has a monoisotopic molecular weight of 642.27 Da. … Vilzemetkib is a small molecule drug. The usage of the INN stem '-metkib' in the name indicates that Vilzemetkib is a MET (mesenchymal epithelial transition factor) kinase inhibitor.

  8. Drug

    Tenecteplase

    go.drugbank.com/drugs/DB00031
    ApprovedInvestigational

    It is a 527 amino acid with a substitution of threonine 103 with asparagine and substitution of asparagine 117 with glutamine within the kringle 1 domain, and a tetra-alanine substitution at amino acids … Tenecteplase is a tissue plasminogen activator (tPA) developed from modifications of natural human tPA complementary DNA (cDNA).

    Products: METALYSE FOR INJECTION 10,000 u/vial
  9. Drug

    MCC

    go.drugbank.com/drugs/DB05282
    Investigational

    The product is a sterile biological composition in a sub-micron suspension. It is produced at the Bioniche manufacturing facility in Pointe-Claire, Quebec. … Mycobacterial Cell Wall-DNA Complex (MCC) is formulated from Mycobacterium phlei, a non-pathogenic strain of mycobacteria.

  10. Drug

    9,10-Deepithio-9,10-Didehydroacanthifolicin

    go.drugbank.com/drugs/DB02169
    Experimental

    A specific inhibitor of phosphoserine/threonine protein phosphatase 1 and 2a. It is also a potent tumor promoter. (Thromb Res 1992;67(4):345-54 & Cancer Res 1993;53(2):239-41)